GLP-1 medications should not replace evidence-based fibromyalgia treatment
Early research suggests GLP-1 activation may reduce neuroinflammation and modulate pain perception through multiple biological pathways, potentially offering relief where traditional pain medications have failed
Interestingly, GIPR agonists alone do not typically result in weight loss
We advise against the use of these medications for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
by Sarah Muntel, RD Spring 2026 Nutritional needs change throughout life, from childhood to adolescence and into Read Article by Julia Lloyd, MPH, RD, LDN, CDCES Spring 2026 GLP-1 medications are changing how people manage weight, Read Article